Idebenone

CHEMBL252556 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

338.4 g/mol

LogP

4.3

Phase

4

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

Moleküler Ağırlık

338,4000 g/mol

LogP

4,30

TPSA

72,80 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Parkinson's Disease Epilepsy Migraine Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O

InChI

InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3

Molecular Formula

C19H30O5

HBD / HBA

1 / 5

Döndürülebilir Bağlar

12

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

Yes, Idebenone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL252556. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3686. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Idebenone PillFYI'da

Yapı

Hızlı Veriler

Formül: C19H30O5
Eş Anlamlılar: 3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.